Clinical question comments:After hysterectomy, what is the role of radiotherapy (external beam, brachytherapy) in the management of early stage high risk endometrial cancer?/Stage 1 endometrial cancer

From Cancer Guidelines Wiki

General information on how to comment

  • If you have identified any gaps or errors in the content please suggest suitable text for inclusion.
  • Statements regarding the inclusion/exclusion of issues should be clearly supported by scientific evidence.


How to post a public comment

  1. Create a user account and/or log in with your details
  2. To post a comment, click the blue 'Make a new comment' link below
  3. Fill in the empty boxes
    Warning: You need to fill out the subject line and box!
  4. Attach supporting references and any new papers to go with your comment and to be considered by the author group for inclusion by clicking on "Attach academic evidence".
  5. Press 'save page' to post your comment!


In order to leave a comment, you must be logged into a Cancer Council Australia account.
Log in to your account Create your account




Contents

Thread titleRepliesLast modified
Public comments: Stage 1 endometrial cancer511:14, 8 October 2012

Public comments: Stage 1 endometrial cancer

Click “Reply” in the bottom right corner and an empty comment box will open. The exact wording of your comment will appear in the discussion thread, but cannot be edited by other users.

PLEASE ENSURE TO CLICK 'SAVE' TO SUBMIT YOUR COMMENT!

IF POSSIBLE, COULD YOU PLEASE INCLUDE YOUR NAME AND ORGANISATION TO ENABLE US TO CONTACT YOU IF WE NEED TO CLARIFY YOUR COMMENT

General information on how to comment

  • If you have identified any gaps or errors in the content please suggest suitable text for inclusion.
  • Statements regarding the inclusion/exclusion of issues should be clearly supported by scientific evidence.


Jutta von Dincklage15:02, 17 June 2011

Do you mean Portec 2 rather than Portec 28?

1.152.207.7217:42, 22 July 2011

Thank you for your comment. You are correct, this was a typographical error. 8 is the reference number and this has now been inserted next to the 2 in the text and also listed in the reference list. Regards, Christine Vuletich Manager, Clinical Guidelines Network Cancer Council Australia

Christine Vuletich13:58, 28 July 2011
 

"Blake et al[4] in the most recent meta-analysis does not support any overall survival benefit with pelvic EBRT"

Consideration should be given to including at statement regarding the benefit that pelvic and vaginal vault brachytherapy does provide. Ida Ackerman comments in the IJGC Supplement in Sept 2010 on this topic quite eloquently. It is useful to bear in mind the progression-free survival benefit from radiotherapy (both EBRT & VBT).

Dr Pearly Khaw Radiation Oncologist Peter MacCallum Cancer Centre

203.4.164.101:04, 18 August 2011

Sorry, I should have added, "even though this is stated in your recommendations". I believe this does need to be emphasised. Pearly

203.4.164.101:13, 18 August 2011
 

Dear Dr Khaw,

Thank you for providing comment on the draft guidelines.

The Working Party has recently met to consider all the public comments received and review the guidelines.

The following is their response to your comments above:

Leave as is. The current recommendation does make that statement, however, can’t be made stronger because the evidence does not allow it. Not strong enough evidence to include the suggested reference in the evidence summary.

Christine Vuletich

Manager, Clinical Guidelines Network

Cancer Council Australia

Christine Vuletich17:02, 27 September 2011